respiratory infections (ARI), approximately accounting for 80% of all deaths suffering from this disease, 5 which was more frequent in developing countries. 6 Moreover, the incidence rate of CAP in children was nearly 22%, and there were about 55,000 children deaths every year caused by CAP in China. 7 Although the pathological mechanism of CAP has not been clearly elucidated, many researchers have focused their attentions on genetic factors in CAP. 8 For instance, the GG genotype and G allele of −174 G/C in IL-6 (an anti-inflammatory cytokine) had a close relation to the susceptibility of CAP in Egyptian children, as suggested by
Zidan et al 9 The human T-cell immunoglobulin mucin (TIM) gene family, located on the human chromosome 5q23-35, contains three members, including TIM-1, TIM-3, and TIM-4, 10 which was shown to be relevant to the immune dysfunction, consequently inducing various diseases, such as autoimmune diseases, allergic diseases, chronic viral infections (CVI), immune rejections, and even tumors. 11 As the first identified gene, TIM-1, also known as HAVCR1, was responsible for regulating immune responses and maintaining immune homeostasis, which had relations to several human inflammatory diseases, 12 and took part in the occurrence and progression of pneumonia. In the study by Fan et al, patients
with mycoplasma pneumoniae pneumonia (MPP) were statistically different from healthy controls in the tilters of TIM1, and blocking TIM1 expression may reduce the risk of MPP-induced damages in heart and liver. 13 In recent years, many scholars have focused on the effects of TIM-1 gene polymorphisms and diseases. For instance, the −1637A > G and −232A > G single nucleotide polymorphisms (SNPs) in the TIM-1 gene were demonstrated to be linked to the susceptibility to rheumatoid arthritis (RA) by Xu et al 14 Meanwhile, Kim et al showed that the insertion of a 6-aminoacid in TIM-1 (157insMTTTVP) had some impact on a Hepatitis A virus (HAV)-induced severe liver disease. 15 More importantly, the two common SNPs (−1454 G>A (rs41297579) and −416 G>C (rs9313422) within TIM-1 were associated with respiratory diseases, like asthma, 16, 17 but it has not been explored whether they have something to do with the susceptibility to CAP. Given the above, 112 children with CAP and 120 healthy controls were recruited as the subjects of study, and polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) was used for the genotyping, to investigate the relationship between SNPs including rs9313422 G>C and rs41297579 G>A in the promoter region of TIM-1 and the risk of in children with CAP.
| MATERIAL S AND ME THODS

| Ethics statement
This study got the approval of the Ethics Committee in Maternal and Child Health Hospital of Jingzhou City and strictly followed the Helsinki declaration. 18 The guardians of all patients signed an informed consent prior to study and agreed to the information collection and blood collection in clinical trials. (1)- (4) and (5) . And the pneumonia of patients can be identified as community-acquired if they had no history of hospitalization during the 2 weeks prior to admission. In addition, the control group consisted of another 120 healthy children who underwent physical examination during the same period in our hospital.
| Subjects of study
| Inclusion and exclusion criteria
All subjects were unrelated Chinese (Han nationality), who were newly diagnosed and treated. The exclusion criteria were as follows:
patients who combined with respiratory diseases, such as tuberculosis, non-infectious interstitial lung diseases, pulmonary edema, pulmonary atelectasis, pulmonary embolism, pulmonary eosinophilia, and pulmonary vasculitis, and particularly asthma; patients who were with a history of surgery or operations, serious dysfunction of heart, liver, kidney, lung or other organs, immunodeficiency, tumors or a history of tumor, hematologic disorders, severe damage in central nervous system, diabetes mellitus, obesity, or other infectious diseases; patients who exhibited poor compliance in the blood collection process; and patients who were unsuitable for intravenous blood sampling.
| Isolation of genomic DNA
Fasting peripheral sample (3 mL) was extracted from peripheral venous blood of all subjects, which were anti-coagulated with the addition of EDTA and centrifuged for 10 minutes at the rate of 1500 g.
Next, DNA extraction kit (Takara Company) was used to extract the whole blood DNA followed by the determination for the purity by a DNA concentration detector (NANODROP2000, Thermo Company), with the A260/A280 ratio between 1.6 and 1.8. The DNA extracted was preserved at −20°C in a refrigerator.
| Genotyping
Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was applied for the genotyping of − 1454 G>A (rs41297579) and −416 G>C (rs9313422). 11 The primer sequences Thermal Cycler (BioRad Laboratories). Besides, the products of PCR (3.5 μL) were purified with a PCR purification kit (Takara Biologicals), followed by digestion with corresponding locus specific restriction enzymes (Takara Biologicals), including TaqI (rs9313422 G>C) or
MspI (rs41297579 G>A) in 10 μL solution for 2-3 hours. The digested PCR products were added into 2% agarose gel (containing ethidium bromide) for electrophoresis. About 10% of the samples were randomly sent for DNA sequencing.
| Statistical method
Data processing was performed with the statistical software SPSS 21.0 (SPSS Inc). Hardy-Weinberg equilibrium was applied to evaluate the representativeness of rs9313422 G>C and rs41297579 G>A in the Case and control groups. Logistic regression analysis was used to calculate the odd ratio (OR) and 95% confidence intervals (CI), so as to estimate the strength of association between the mutation of polymorphic loci and CAP in children. Enumeration data were presented by rate or ratio, which was compared by using Chi-Square (χ 2 ) test.
Measurement data were presented by mean ± standard deviation (x ±s). Comparison between two groups was analyzed by Student's ttest. Comparison among multiple groups was conducted by using oneway ANOVA followed by using Tukey's post hoc test. A two-tailed P value < .05 indicated that the difference was of statistical significance.
| RE SULTS
| Baseline characteristics of subjects
The baseline characteristics of 112 CAP patients in the case group were shown in Table 1 . There are 64 males and 48 females with the average age of 57.55 ± 37.17 months (3-118 months). In addition, healthy subjects in the control group were consisted of 62 males and 58 females with the average age of 57.00 ± 31.63 months (4-110 months).
Obviously, no statistical difference was found between the case group and the control group in age and gender (both P > .05).
| Genotyping and sequencing of rs9313422 G>C and rs41297579 G>A in the promoter region of TIM-1
The PCR amplification product of rs9313422 G>C was 879bp in length. The digestion products showed three genotypes, including CC (a single uncuttable fragment of 879bp), GG (two fragments of 488bp and 391bp), and GC (three fragments of 879bp, 488bp, and 391bp), as shown in Figure 1A . After DNA sequencing, it was confirmed that GG genotype had only one G peak, CC genotype had only one C peak, while GC genotype had both a G peak and a C peak ( Figure 1B-C) . In addition, the PCR amplification product of rs41297579 G>A was 515bp, and MspI cut the 515bp PCR product into two fragments of 399bp and 116bp length. A single 515bp band exhibited the presence of AA genotype; fragments 399bp and 116bp indicated the presence of the GG genotype and three fragments of 515bp, 399bp, and 116bp displayed the presence the GA genotype (Figure 2A) . Meanwhile, DNA sequencing showed that GG genotype had only one G peak, AA genotype had only one A peak, while GA genotype had both a G peak and an A peak ( Figure 2B -C). 
TA B L E 1 Baseline characteristics of 112 CAP children
| Association of TIM-1 rs9313422 G>C and rs41297579 G>A polymorphisms with the risk of CAP in children
Hardy-Weinberg equilibrium (HWE) test showed that the genotype frequencies of TIM-1 rs9313422 G>C and rs41297579 G>A in the control group were in genetic equilibrium, indicating that the sample analyzed was representative of the population (Table 2) . Besides, as illustrated in Table 3 (Table 4) .
| Association of TIM-1 rs9313422 G>C and rs41297579 G>A polymorphisms with the clinical characteristics of CAP in children
Stratified analysis was carried out based on the clinical characteristics of CAP in children (Table 5) , and the result demonstrated that under the dominant model, both rs9313422 G>C and rs41297579 G>A polymorphisms were related to the severity of CAP in children (all P < .05), but they had no correlations with gender, identified pathogens and mortality of children with CAP (all P > .05). In addition, rs9313422
G>C had an impact on the ICU admission of patients (P < .05).
| Relationship between TIM-1 rs9313422 G>C and rs41297579 G>A polymorphisms and inflammatory responses of CAP in children
As presented in Figure 3 , CAP patients who carried with the mutant genotypes of rs9313422 G>C (GC and CC) had remarkably higher in WBC than GG genotype carriers (all P < .05); meanwhile, the AA genotype carriers in rs41297579 G>A revealed a higher WBC, as compared with the GG and GC genotype carriers (all P < .05). However, there was no significant difference in terms of WBC between TA B L E 3 Association of TIM-1 rs9313422 G>C and rs41297579 G>A polymorphisms with the risk of children CAP in children patients carrying GG genotype and those carrying GC genotypes of rs9313422 G>C (P > .05). Moreover, the levels of PCT and CRP were statistically higher in patients carrying the homozygous mutant of rs9313422 G>C and rs41297579 G>A than those of corresponding homozygous wild type and heterozygous carriers (all P < .05), but no significant difference was observed between homozygous wild-type carriers and heterozygous genotype carriers with respect to the PCT and CRP levels (all P > .05).
| D ISCUSS I ON
In recent years, a large body of studies has found that the genetic polymorphisms of TIM-1 were correlated with the risk of a variety of diseases, including asthma, 20 hepatitis C persistence, 21 childhood atopic dermatitis, 22 and systemic lupus erythematosus (SLE). 23 In this study, we analyzed two SNPs in the human promoter region of TIM-1 gene by performing genotyping via PCR-RFLP, and we found that the C allele of rs9313422 G>C and the A allele of rs41297579 G>A were significantly associated with the increased risk of CAP in children. Consistent with our finding, these two SNPs were also demonstrated to be related to the susceptibility of allergic rhinitis, as suggested by Mou et al 24 rs9313422 G>C may function as a predisposing factor for atopic asthma and childhood allergic asthma. 16, 17 In the study by Xie et al, the rs9313422 CC genotype and rs41297579 AA genotype could greatly affect the susceptibility and prognosis of dilated cardiomyopathy, 11 indicating that the gene mutation of rs9313422 G>C and rs41297579 G>A might be a risk factor for multiple diseases along the above evidence, as well as in children with CAP. As we know, both of the two SNPs were located in the promoter region TA B L E 4 Haplotype association analysis to CAP children using the two SNPs (rs9313422 G>C -rs41297579 G>A) Furthermore, we used the online software SHEsis to carry out haplotype analysis, and the result demonstrated both haplotypes GA and GG could effectively reduce the risk of CAP in children.
As such, we hypothesized that the TIM-1 promoter haplotype together with T-cell receptor can induce the production of anti-inflammatory Th2 cytokines, and thus having a protective effect on CAP; while CA genotype can significantly increase the risk of childhood CAP.
As one of the most common community-acquired infections, CAP usually means the necessity of ICU admission. 27 Severe CAP is a major cause of patients' mortality, and about 12%-36% CAP patients in the ICU die within a short period despite the application of effective antibiotic therapies. 28 To date, numerous studies have proved the association of gene polymorphisms with the severity and prognosis of CAP patients. For instance, Gallagher et al observed a significant increase in the G allele frequency of IL-10 in CAP patients with the increase in illness severity. 29 In the study by Yende et al, the existence of C allele at the −173 G/C position of macrophage migration inhibitory factor (MIF) gene was relevant to the higher 90-d survival of CAP patients. 30 In the current research, we found that under the dominant model, both rs9313422 G>C and rs41297579 G>A were related to the severity of childhood CAP, and rs9313422 G>C was also associated with patients' admission rate of ICU, which highlighted the impacts of these two SNPs on the progression and prognosis of CAP in children. Besides, it was also worthy to mention that the patients who carried with the mutant genotypes of rs9313422 G>C and rs41297579 G>A showed a non-statistically higher mortality rate than those wild-type genotype carriers, which may be attributed In summary, the C allele of rs9313422 G>C and A allele of rs41297579 G>A in the promoter region of TIM-1 could increase the risk of CAP in children, which were associated with the inflammatory responses and disease severity. Besides, the haplotypes GA (rs9313422-rs41297579) and GG could reduce the risk of CAP in children, while CA could elevate the risk.
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